Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MIRENA 52 MG — DIN 02243005

LEVONORGESTREL : 52 MG · BAYER INC · INSERT (EXTENDED-RELEASE) · wholesale supply in Canada

Health Canada status: MARKETED

What is MIRENA?

MIRENA 52 MG contains LEVONORGESTREL : 52 MG. It is listed in the Health Canada Drug Product Database under DIN 02243005, held by BAYER INC, supplied as INSERT (EXTENDED-RELEASE) for INTRAUTERINE administration. Health Canada currently lists it as marketed, status dated 22-Nov-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MIRENA used for?

Conception control for up to 8 years; treatment of idiopathic menorrhagia for up to 5 years in individuals accepting the contraceptive effect.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How much does Plastic Iud With Progestogens cost around the world?

Plastic Iud With Progestogens is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Brazil publishes a preco fabrica (ex-factory ceiling). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
SpainPVP con IVA (public price)2626EUR███.██
South Africasingle exit price2020ZAR███.██
Australiaex-manufacturer1617AUD███.██
Brazilpreco fabrica (ex-factory ceiling)1114BRL███.██
SwedenAIP (pharmacy purchase price)714SEK███.██
Norwaymax AUP (pharmacy retail)912NOK███.██
Saudi Arabiapublic46SAR███.██
MoroccoPPV (public price)34MAD███.██
United Statesacquisition13USD███.██
Bahrainretail (max)22BHD███.██
United Kingdomhospital22GBP███.██
Romaniamax producer price22RON███.██
United Arab Emiratespublic11AED███.██
Greeceproducer price (ex-factory)11EUR███.██

124 pack listings across 105 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Plastic Iud With Progestogens pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Plastic Iud With Progestogens in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

Only one market authorization holder has a Canadian DIN containing Plastic Iud With Progestogens — 3 DINs, of which 2 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.

Market authorization holderDINsMarketedBrand namesPosition
BAYER INC32JAYDESS, KYLEENA, MIRENASourceable in Canada

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label52 MG
Dosage formINSERT (EXTENDED-RELEASE)
RouteINTRAUTERINE
Pack configuration (monograph)Supplied in a sterile package with an inserter and a reminder card. Sterilized with ethylene oxide. Single use only.
StorageNot explicitly detailed in provided text snippet (refer to section 11 of full monograph). Standard instructions: Do not use after expiry date.

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substancePlastic Iud With Progestogens
ATC codeG02BA03
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02243005
DIN (unpadded, as printed on some documents)2243005
Brand nameMIRENA
Generic / active ingredientLEVONORGESTREL : 52 MG
Market authorization holderBAYER INC
Health Canada schedulePrescription
ATC codeG02BA03
ATC anatomical main groupG — Genito-urinary system and sex hormones
ATC therapeutic subgroupG02BA
Current statusMARKETED
Status date22-Nov-2007
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

How is it administered?

Inserted into the uterine cavity by a healthcare professional. Effective for up to 8 years for contraception and 5 years for idiopathic menorrhagia. Follow specific aseptic insertion instructions.

Included because it drives pack selection and wastage. Consult the monograph.

Contraindications

Pregnancy, pelvic inflammatory disease, lower genital tract infection, postpartum endometritis, undiagnosed uterine bleeding, uterine anomalies/fibroids, malignancies, liver disease, endocarditis.

Warnings and precautions

Does not protect against STIs/HIV. Smoking increases cardiovascular risk. Risk of uterine perforation and expulsion. Clinical examination required before and after insertion.

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

2 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
KYLEENA19.5 MGINSERT (EXTENDED-RELEASE)BAYER INCMARKETED02459523
JAYDESS13.5 MGINSERT (EXTENDED-RELEASE)BAYER INCCANCELLED POST MARKET02408295

2 · Same class — other molecules in ATC G02BA

MoleculeCanadian brandsDINsMarketedSourceable
Plastic Iud With ProgestogensJAYDESS · KYLEENA · MIRENA32Yes

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC G02B

ATC subgroupMoleculesDINsMarketed
G02BBVaginal Ring With Progestogen And Estrogen33

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is MIRENA called?

The same molecule, Plastic Iud With Progestogens, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
KyleenaLatinAustralia, Brazil, Norway, South Africa
LEVONORGESTRELLatinBrazil
LeveretteLatinSweden
Levonorgestrel/Etinylestradiol EbbLatinSweden
Logynon EDLatinAustralia, South Africa
MicrogynonLatinNorway
MicrovalLatinMorocco, South Africa
NORLEVOLatinMorocco, South Africa
PrionelleLatinSweden
RigevidoncontLatinSweden
AvibelaLatinSouth Africa
DIADLatinBrazil
EkuvorLatinSouth Africa
Escapelle TabletLatinSouth Africa
EsteloLatinSouth Africa

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MIRENA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 11 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02243005. Last reviewed 2026-09-11. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.